Previous 10 | Next 10 |
HHS has sent letters to six pharmaceutical companies saying they may now face fines for refusing to appropriately comply with the federal government's 340B drug discount program. The companies are: AstraZeneca (AZN +1.1%), Eli Lilly (LLY +2.0%), Novartis (NVS +1.2%), Novo Nordisk (NVO +1...
United Therapeutics Releases its Annual Corporate Responsibility Report Report available at corporateresponsibility.unither.com PR Newswire SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Sept. 10, 2021 /PRNewswire/ -- United Therapeutics C...
United Therapeutics Presents Tyvaso DPI™ BREEZE Clinical Data At The European Respiratory Society International Congress 2021 In subjects with PAH, transition from Tyvaso® to Tyvaso DPI™ demonstrated safety and tolerance with significant improvements in six-mi...
United Therapeutics Partners with Former NFL Player Devon Still and His Daughter Leah to Launch "Braving NeuroBLASToma" in Honor of Childhood Cancer Awareness Month - Neuroblastoma is the most common cancer in infants less than one year old and the third-most common pediatric ca...
United Therapeutics to Present Tyvaso DPI™ BREEZE Clinical Data at the European Respiratory Society International Congress 2021 PR Newswire SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Aug. 24, 2021 /PRNewswire/ -- United Therapeutics Cor...
Jefferies is out with a list of "exceptional"-upside stocks for some high-volatility times - an exercise it admits is akin to "panning for gold in whitewater." But the names and target prices it lists are, on average, offering about 60% upside from current levels, and their most bullish cases...
Insiders Are Scooping Up Shares Of These Penny Stocks Right Now Trying to track down the best penny stocks to buy right now ? Some traders will focus on technical indicators and charts. Others may look for news headlines or earnings reports. There’s another train of thoug...
LQDA is trying to bring a Tyvaso competitor to the market that allegedly works better. United is doing all it can to stop that. UTHR CEO Martine Rothblatt has a reputation as a capable fighter. For further details see: Liquidia: Martine Rothblatt's United Therapeutics Is...
A federal court in Delaware has ruled that AstraZeneca (AZN -2.7%) is not required to offer discounted drugs under the 340B program to an unlimited number of pharmacies, dealing a blow to the Department of Health and Human Services ("HHS"). The program is designed to provide discounted drugs ...
CLGN's platform-technology is underscored by its recent AbbVie partnership. Royalty model company that is debt-free, and well funded. Recent partnership with 3D Systems creates end-to-end bioprinting partnership with multiple end-market opportunities to pursue. Company current...
News, Short Squeeze, Breakout and More Instantly...
United Therapeutics Corporation Company Name:
UTHR Stock Symbol:
NASDAQ Market:
United Therapeutics Corporation Website:
A look at the top 10 most actives in the United States Aptevo Therapeutics Inc. (APVO) rose 45.1% to $0.486 on volume of 64,992,551 shares Verb Technology Company Inc. (VERB) rose 3.5% to $0.1205 on volume of 54,410,242 shares NVIDIA Corporation (NVDA) fell 4.4% to $120.752 on volume of 4...
2024-07-11 06:30:06 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for UTHR on July 11, 2024 04:53AM ET. The previous analyst recommendation was Overweight. UTHR was trading at $329.25 at issue of the analyst recommendation. The overall analyst consensus : ...
Over 100,000 patients in the United States have IPF, with two approved therapies available that only slow the course of disease progression Top line data expected in the second half of 2025 United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announ...